reported that many of the 7-aminothiazolyl cephalosporins, such as cefmenoxime, showed paradoxically reduced activity against Proteus vulgaris at higher concentrations, whereas these paradoxical effects were not observed for other types of cephalosporins, such as cefbuperazone and cefoperazone. In this study, we compare the therapeutic effect of cefmenoxime with that of cefbuperazone and explore the in vivo paradoxical effect of cefmenoxime by using an experimental infection model in mice. In an intraperitoneal infection with P. vulgaris 11, the survival rate with cefmenoxime was increased to 43% at 3.13 mg/kg but was lower at higher doses. On the other hand, cefbuperazone did not show such a paradoxical therapeutic effect. In mice infected with P. vulgaris 11, cefmenoxime levels in both serum and peritoneal washings were rapidly reduced and f-lactamase activities in the peritoneal cavity were increased at higher cefmenoxime doses. These findings suggested that high levels of cefmenoxime at the infection site induced increased production of j(-lactamase, which then rapidly inactivated the antibiotic. We conclude that the paradoxical therapeutic effect of cefmenoxime against P. vulgaris occurs by the same mechanisms as the in vitro effect and that the high P-lactamase inducibility and low (-lactamase stability may account for the paradoxical therapeutic effect of cefmenoxime against P. vulgaris.The antibacterial activity of an antibiotic is generally proportional to its concentration. However, several exceptions to this trend have been reported (3, 9, 13). In previous papers (4, 5), we reported that some 7-aminothiazolyl-type cephalosporins showed paradoxically reduced activities against Proteus vulgaris when they were present at high concentrations. Indeed, it has been difficult to demonstrate such paradoxical antibacterial activity clinically, but it appears that the in vivo paradoxical effect can be confirmed by using an experimental infection model. Eagle et al. (2), using an animal model of Staphylococcus aureus infection, found that the paradoxical antibacterial effect holds true in vivo. However, the mechanism of this effect was not explained sufficiently. In this study, we confirm that cefmenoxime has a paradoxical therapeutic effect in an experimental intraperitoneal model of P. vulgaris infection in mice. We also investigate the mechanism involved.
MATERIALS AND METHODSAntibiotics. Cefmenoxime, prepared by Takeda Chemical Industries, Co., Ltd., Osaka, Japan, and cefbuperazone, prepared by Toyama Chemical, Co., Ltd., Tokyo, Japan, were used as the test antibiotics.Bacterial strains. P. vulgaris 11 and P. vulgaris 11-S, a ,-lactamase-noninducing mutant of P. vulgaris 11 (4), were used in this study.Intraperitoneal infection. Male ICR strain mice (Shizuoka Agricultural Cooperative Associations for Laboratory Animals, Shizuoka, Japan) weighing 18 to 19 g were used in this study. Bacterial cells from an overnight culture on heart infusion agar (Eiken Chemical, Tokyo, Japan) were suspended in physiological...